PHUSE FDA/ CSS 2023
CSS Chairs | ||
|---|---|---|
Chris Price, PHUSE Working Groups Director | Lilliam Rosario, FDA Director, Office of Computational Science, CDER |
Jean-Marc Ferran, Qualiance Independent Consultant & |
In today's rapidly evolving world of pharmaceuticals and healthcare, data-driven decision-making has become paramount. Regulatory agencies, such as the FDA, are increasingly relying on computational science and data analytics to expedite drug development, enhance safety assessments, and ensure the efficacy of new treatments. Year after year, the PHUSE/FDA Computational Science Symposium (CSS) continues to be a driving force behind shaping the future of drug development and regulatory science. The event stands as a testament to the pharmaceutical industry’s commitment to innovation and collaboration. We are pleased to have welcomed over 210 attendees to Silver Spring. 31 poster presentations, 3 Hands-on Workshops, 2 Panel Discussions and 30+ Working Group Breakout Sessions filled the three event days with inspiration. PHUSE/FDA CSS will return for its 14th year from 3-5 June 2024. In the meantime, you can catch up on CSS 2023 content available on the PHUSE Archive. For more information on PHUSE Working Groups, please contact workinggroups@phuse.global. |
|  |
|
CSS Contributors | ||
|---|---|---|
|
